Background: Electronic cigarettes (e-cigarettes) are the most commonly used tobacco products among U.S. youth. This study examined time since initiation among current adolescent e-cigarette users.

Methods: Data were drawn from the 2019-2022 National Youth Tobacco Survey, and the study sample included adolescents who reported ≥ 1 day of e-cigarette use in the past 30 days (n = 9,424). Time since initiation was calculated by subtracting the age of first e-cigarette use from the current age, then classified as < 1 year, 1 year, 2 years, and ≥ 3 years. Logistics regressions were performed to examine the change in time since initiation (≥3 years vs. < 3 years) from 2019 to 2022 and associations of time since initiation with tobacco use and adverse health outcomes.

Results: The proportion of current e-cigarette users with time since initiation < 1 year decreased from 29.6 % in 2019 to 13.2 % in 2022, while the proportion of those with time since initiation ≥ 3 years increased from 16.5 % to 46.0 % (p < 0.0001). The increases in time since initiation ≥ 3 years were observed across demographic groups. Longer time since initiation (≥3 years vs. < 3 years) was associated with lower odds of vaping quit intention (AOR=0.6[0.4-0.8],p = 0.0003) and higher odds of frequent e-cigarette use (AOR=3.0[2.3-4.0],p < 0.0001), dual use of e-cigarettes and other tobacco products (AOR=1.7[1.3-2.3],p = 0.0005), tobacco craving (AOR=2.2[1.5-3.1],p < 0.0001), tobacco dependence (AOR=1.9[1.2-3.0],p = 0.004) and the presence of cognitive impairment (AOR=1.3[1.04-1.73],p = 0.03) CONCLUSIONS: The findings of this study underscore the need for comprehensive public health initiatives, accessible cessation programs, and effective tobacco control policies to curb prolonged e-cigarette use in early life.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addbeh.2024.108165DOI Listing

Publication Analysis

Top Keywords

time initiation
12
initiation current
8
current vaping
4
vaping adolescents
4
adolescents associations
4
associations adverse
4
adverse health
4
health outcomes
4
outcomes background
4
background electronic
4

Similar Publications

Retinal detachment after acute retinal necrosis: a retrospective analysis of hospitalized patients.

Jpn J Ophthalmol

January 2025

Department of Visual Science and Ophthalmology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Purpose: To review hospitalized patients with Acute Retinal Necrosis (ARN) and investigate factors associated with subsequent retinal detachment (RD).

Study Design: Retrospective.

Methods: The study included 40 patients (42 eyes), categorized into non-RD (23 eyes) and RD (19 eyes) groups.

View Article and Find Full Text PDF

Liver cancer poses a global health challenge with limited therapeutic options. Notably, the limited success of current therapies in patients with primary liver cancers (PLCs) may be attributed to the high heterogeneity of both hepatocellular carcinoma (HCCs) and intrahepatic cholangiocarcinoma (iCCAs). This heterogeneity evolves over time as tumor-initiating stem cells, or cancer stem cells (CSCs), undergo (epi)genetic alterations or encounter microenvironmental changes within the tumor microenvironment.

View Article and Find Full Text PDF

Background & Aims: Hepatic encephalopathy (HE), one of the most serious prognostic factors for mortality in alcohol-related cirrhosis (ALD cirrhosis), is not recorded in Danish healthcare registries. However, treatment of HE with lactulose, the universal first-line treatment, can be identified through data on filled prescriptions. This study aimed to investigate if lactulose can be used as a surrogate marker of HE.

View Article and Find Full Text PDF

Introduction: Therapeutic drug monitoring (TDM) in inflammatory rheumatic diseases (RMDs) is gaining interest. However, there are unresolved questions about the best practices for implementing TDM effectively in clinical settings.

Objective: The primary objective of this study was to evaluate whether early TDM of adalimumab predicts drug survival at 52 weeks in patients with RMDs.

View Article and Find Full Text PDF

Role of immune cell homeostasis in research and treatment response in hepatocellular carcinoma.

Clin Exp Med

January 2025

Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.

Introduction Recently, immune cells within the tumor microenvironment (TME) have become crucial in regulating cancer progression and treatment responses. The dynamic interactions between tumors and immune cells are emerging as a promising strategy to activate the host's immune system against various cancers. The development and progression of hepatocellular carcinoma (HCC) involve complex biological processes, with the role of the TME and tumor phenotypes still not fully understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!